TrialDiabetes, obesity & metabolism2020

A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.

Luigi F Meneghini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.